A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance
Condition:   Hypercholesterolemia Interventions:   Drug: K-877 0.2 mg/day (once daily);   Drug: K-877 0.4 mg/day (once daily);   Drug: Placebo (once daily) Sponsor:   Kowa Company, Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Conditions:   Primary Sclerosing Cholangitis;   Inflammatory Bowel Diseases Intervention:   Drug: Rosuvastatin Sponsor:   Stanford University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials